Insider Transactions in Q4 2020 at Sigilon Therapeutics, Inc. (SGTX)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 08
2020
|
Coelho Rogerio Vivaldi PRESIDENT AND CEO |
BUY
Conversion of derivative security
|
Direct |
22,222
+50.0%
|
-
|
|
Dec 08
2020
|
John Cox |
BUY
Conversion of derivative security
|
Indirect |
4,444
+50.0%
|
-
|
|
Dec 08
2020
|
Flagship Ventures Fund V General Partner LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
10,370,369
+50.0%
|
-
|
|
Dec 08
2020
|
Lilly & CO Eli > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
300,000
+9.85%
|
$5,400,000
$18.0 P/Share
|
|
Dec 08
2020
|
Lilly & CO Eli > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,444,443
+50.0%
|
-
|